IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 32.794

Change

+0.13 (+0.39)%

Market Cap

N/A

Volume

100.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.07 (+0.32%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.07 (-0.12%)

USD 35.41B
DFAC Dimensional U.S. Core Equity 2..

+0.08 (+0.23%)

USD 30.37B
DTB DTE Energy Company 2020 Series

+0.05 (+0.23%)

USD 26.58B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 25.69B
JPST JPMorgan Ultra-Short Income ET..

+0.03 (+0.06%)

USD 25.59B
GBTC Grayscale Bitcoin Trust (BTC)

+0.82 (+1.63%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

+0.03 (+0.03%)

USD 13.04B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 12.23B
DFUV Dimensional US Marketwide Valu..

+0.06 (+0.14%)

USD 11.10B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.90% 48% F 52% F
Dividend Return 0.88% 24% F 19% F
Total Return 9.78% 47% F 47% F
Trailing 12 Months  
Capital Gain 24.13% 65% D 65% D
Dividend Return 1.00% 15% F 12% F
Total Return 25.13% 62% D 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.71% 73% C 55% F
Dividend Return 5.04% 70% C- 48% F
Total Return 0.33% 19% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 7.08% 64% D 85% B
Risk Adjusted Return 71.14% 82% B 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.